Rockwell Medical (RMTI) Capital Expenditures Growth (1y) (2011 - 2026)
Rockwell Medical (RMTI) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -21.54% |
| 10 | Rockwell Medical | 28.43 Mn | 4.54 Mn | 2.90 Mn | 574.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 574.60% |
| Dec 31, 2025 | -78.23% |
| Sep 30, 2025 | 19.90% |
| Jun 30, 2025 | -42.66% |
| Mar 31, 2025 | -54.68% |
| Dec 31, 2024 | 818.60% |
| Sep 30, 2024 | 1,093.75% |
| Jun 30, 2024 | 257.50% |
| Mar 31, 2024 | -4.14% |
| Dec 31, 2023 | -84.70% |
| Sep 30, 2023 | 120.00% |
| Jun 30, 2023 | 56.86% |
| Mar 31, 2023 | 400.00% |
| Dec 31, 2022 | 146.49% |
| Sep 30, 2022 | -162.99% |
| Jun 30, 2022 | -79.01% |
| Mar 31, 2022 | -23.68% |
| Dec 31, 2021 | 50.00% |
| Sep 30, 2021 | -81.51% |
| Jun 30, 2021 | 203.75% |